Juglone: ?A novel immunomodulatory, antifibrotic, and schistosomicidal agent to ameliorate liver damage in murine schistosomiasis mansoni?

Schistosomiasis remains one of the world's leading health concerns, affecting millions. The granulomatous reaction is the most significant immunopathological change associated with Schistosoma mansoni infection, resulting in significant mortality. Recent progress has been made in the search for new natural compounds to reduce schistosomiasis and its immunopathology. Walnuts contain the phenolic compound Juglone (5-hydroxy1,4-naphthoquinone), which has antiparasitic, anti-inflammatory, immunoregulatory, and antioxidant properties. There were three groups of infected mice: untreated (IU), Juglone-treated (JUG T), and praziquantel-treated (PZ). In mice treated at 8 mg Juglone /kg body weight, a reduction of 63.1 % and 52.1 % were observed in the number of male and female worms, respectively. In addition, the number of eggs/g tissue was reduced by 65.7 % in the liver, 58.58 % in the intestine, and 62.31 % in the liver and intestine combined. In addition, Juglone decreased hepatic granuloma size by 55.1 % and collagen fiber deposition by 23.4 % compared to PZQ (41.18 % and 11.2 %, respectively). Interestingly, the JUG T group had significantly lower levels of IL-4, IL-13, IL-37, TNF alpha, TGF-beta, and IFN-gamma than PZ mice (p < 0.05). While IL-10 and IL-17 levels rose (p < 0.01), Juglone could restore hepatic ALT, AST, GGT, and LDH activities following infection. In addition, it increased catalase, SOD, GSH, and GST while decreasing NO and LPO in comparison to the infected group. Moreover, anti-SWAP, SEA, and CAP IgG levels increased significantly. IgE levels did not change significantly, however. Juglone could be used as an antifibrotic, immunomodulatory, and schistosomicidal agent; thus, it could be used in place of PZQ.